共 27 条
- [1] Almutairi K., Et al., The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review, Rheumatol Int, 41, pp. 863-877, (2021)
- [2] Alivernini S., Firestein G.S., McInnes I.B., The pathogenesis of rheumatoid arthritis, Immunity, 55, pp. 2255-2270, (2022)
- [3] Singh J.A., Treatment guidelines in rheumatoid arthritis, Rheum Dis Clin North Am, 48, pp. 679-689, (2022)
- [4] Loppenthin K., Et al., Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: A nationwide register study, J Comorb, 9, (2019)
- [5] Listing J., Gerhold K., Zink A., The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment, Rheumatology (Oxford), 52, pp. 53-61, (2013)
- [6] Krabbe S., Et al., Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model, Rheumatology (Oxford), 60, pp. 3834-3844, (2021)
- [7] Ahmed S., Gasparyan A.Y., Zimba O., Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic, Rheumatol Int, 41, pp. 243-256, (2021)
- [8] Hsu C.Y., Et al., Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study, Arthritis Res Ther, 21, (2019)
- [9] Mehta P., Et al., Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management, Clin Rheumatol, 41, pp. 2893-2910, (2022)
- [10] Friedman M.A., Winthrop K., Vaccinations for rheumatoid arthritis, Curr Opin Rheumatol, 28, pp. 330-336, (2016)